期刊文献+

河南省新郑市HBV感染孕妇母婴阻断效果及乙肝相关知识知晓情况调查 被引量:4

Status of Hepatitis B related knowledge and mother-to-child transmission prevention in pregnant women with HBsAg positive in Xinzheng,Henan
原文传递
导出
摘要 目的 了解乙肝相关知识的知晓情况,分析HBV感染孕妇母婴阻断影响因素,为提高母婴阻断效果提供参考。方法 对2018年5月至2019年10月在河南省新郑市所有医院孕产妇HBV感染情况进行筛查和登记,对参与母婴阻断效果研究的对象进行问卷调查,主要内容包括一般人口学信息和乙肝相关知识。实验室检测HBsAg、HBeAg、HBe Ab和HBV DNA。新生儿出生后按照0-1-6月接种乙肝疫苗,在完成全程接种1个月后采集标本,检测HBsAg和HBsAb进行母婴阻断分析。结果 共计调查孕妇18 522名,其中HBV感染占2.8%(528/18 522),参与母婴阻断的192名HBV感染孕妇,平均年龄为(28.9±3.7)岁,大专以上文化程度占45.3%。HBeAg阳性孕妇占29.4%,HBV DNA载量高于2×105 IU/mL的占21.3%,HBV感染孕妇关于乙肝知识的知晓率为83.3%,母婴阻断成功率为97.4%,其中HBeAg(-)和HBeAg(+)母亲所生新生儿母婴阻断成功率分别为100.0%和91.2%,差异有统计学意义(P=0.002),新生儿HBsAb阳性率分别为95.6%和87.7%,差异有统计学意义(χ^(2)=3.899,P=0.048);孕妇HBV DNA载量HBV DNA≥2×10^(5)和<2×10^(5)IU/mL阻断成功率分别是87.7%和100.0%,差异有统计学意义(P=0.000 36)。结论 HBV感染孕妇母婴阻断成功率与HBe Ag阳性与否及病毒载量高低直接相关,提高孕妇乙肝相关知识知晓率,有针对性的进行抗病毒治疗,降低HBV复制活性,是提高母婴阻断成功率的关键。 Objective To understand the knowledge of hepatitis B related knowledge,analyze the influencing factors of maternalinfant blockade in pregnant women with HBV infection,and provide reference for improving the effect of maternal-infant blockade.Methods The HBV infection status of pregnant and lying-in women in all hospitals in Xinzheng city,Henan province from May 2018 to October 2019 was screened and registered,and a questionnaire survey was conducted on the subjects who participated in the study on the effect of mother-to-child interruption.The main contents included general demographic information and Hepatitis B related knowledge.HBsAg,HBeAg,HBeAb and HBV DNA were tested.Newborns were vaccinated with hepatitis B vaccine from 0 to 1 to 6 months after birth.Specimens were collected one month after the whole course of vaccination to detect HBsAg and HBsAb for mother-to-child blocking analysis.Results A total of 18 522 pregnant women were investigated,of which HBV infection accounted for 2.8%(528/18 522),and 192 HBV-infected pregnant women who participated in the mother-to-child interruption were surveyed,with an average age of(28.9 ±3.7) years old,and 45.3% with a college degree or above.HBeAg-positive pregnant women accounted for 29.4%,HBV DNA load being higher than 2×10~5IU/mL accounted for 21.3%,the awareness rate of HBV-infected pregnant women about hepatitis B knowledge was 83.3%,and the success rate of mother-to-child blocking was 97.4%.Among them,the success rates of mother-to-infant blockade of neonates born to HBeAg(-) and HBeAg(+) mothers were 100.00% and 91.2%,respectively,with a statistically significant difference(P<0.002).The positive rates of neonatal HBsAb were 95.6% and 87.7%,respectively,the difference was statistically significant(χ~2=3.899,P=0.048).Pregnant women with HBV DNA load HBV DNA ≥ 2×10~5 and HBV DNA<2×105IU/mL had a successful blocking rate of 87.7% and 100.0%,respectively,and the difference was statistically significant(P=0.000 36).Conclusion The success rate of mother-to-child blockade in pregnant women with HBV infection is directly related to whether HBeAg is positive or not and the level of viral load.Improving the awareness rate of hepatitis B-related knowledge in pregnant women,targeted antiviral treatment,and reducing HBV replication activity are the key to improve maternal-infant resistance.
作者 李伟青 贾永惠 郭永豪 LI Weiqing;JIA Yonghui;GUO Yonghao(Xinzheng Center for Disease Control and Prevention,Xinzheng 451100,China;Henan Provincial Center for Disease Control and Prevention)
出处 《河南预防医学杂志》 2022年第6期417-420,共4页 Henan Journal of Preventive Medicine
基金 河南省医学科技攻关省部共建项目(2018010028)。
关键词 孕妇 HBSAG阳性 HBV感染状态 乙肝知识知晓率 Pregnant woman HBsAg positive HBV infectious status Knowledge of hepatitis B Awareness rate of hepatitis B knowledge
  • 相关文献

参考文献5

二级参考文献59

  • 1Yong P, Suvimol S, Saowani C, et al. Long term hepatitis B vaccine in infants born to hepatitis B e antigen positive mothers [J]. Archives of Disease in Childhood, 1997, 77 ( 1 ) : 47-51.
  • 2国家质量监督检验检疫总局.育龄期妇女信息系统(WIS)基础数据结构与分类代码(GB/T18848-2002).
  • 3Stephen J, McPhee, Thoa N, et al. Successful Promotion of Hepatitis B Vaccinations Among. Vietnamese-American Children Ages 3 to 18: Results of a Controlled Trial[J]. Pediatrics, 2003, 11 (6): 1278-1288.
  • 4Dong Q,Chan HL,Liu Z,Chan DP,Zhang B,Chen Y,Kung HF,Sung JJ,He ML. A1762T/G1764A mutations of hepatitis B virus,associated with the increased risk of hepatocellular carcinoma,reduce basal core promoter activities. Biochem Biophys Res Commun 2008; 374: 773-776.
  • 5Kusakabe A,Tanaka Y,Inoue M,Kurbanov F,Tatematsu K, Nojiri S,Joh T,Tsugane S,Mizokami M. A population-based cohort study for the risk factors of HCC among hepatitis B virus mono-infected subjects in Japan. J Gastroenterol 2011; 46: 117-124.
  • 6Tanaka Y,Mukaide M,Orito E,Yuen MF,Ito K,Kurbanov F,Sugauchi F,Asahina Y,Izumi N,Kato M,Lai CL,Ueda R,Mizokami M. Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. J Hepatol 2006; 45: 646-653.
  • 7Xu L,Qian G,Tang L,Su J,Wang JS. Genetic variations of hepatitis B virus and serum aflatoxin-lysine adduct on high risk of hepatocellular carcinoma in Southern Guangxi,China. J Hepatol 2010; 53: 671-676.
  • 8Fan W,Shi B,Wei H,Du G,Song S. Comparison of hepatitis B X gene mutation between patients with hepatocellular carcinoma and patients with chronic hepatitis B. Virus Genes 2011; 42: 162-170.
  • 9Chu CM,Liaw YF. Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: a longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline. J Hepatol 2005; 43: 411-417.
  • 10Fang ZL,Sabin CA,Dong BQ,Wei SC,Chen QY,Fang KX, Yang JY,Huang J,Wang XY,Harrison TJ. Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study. J Gen Virol 2008; 89: 2882-2890.

共引文献162

同被引文献57

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部